IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Coronis Health Mezzco Pty Ltd
iNova Pharmaceuticals is a Proprietary Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry. In 2021 the company generated total revenue of $193,005,000 including sales and other revenue. In 2021 iNova Pharmaceuticals had 165 employees including employees from all subsidiaries under the company's control. The Chief Executive of iNova Pharmaceuticals is Mr Dan Spira whose official title is Chief Executive Officer - iNova Group. The Chairman of iNova Pharmaceuticals is either not applicable or not available. Coronis Health Mezzco Pty Ltd, trading as iNova Pharmaceuticals, markets and distributes prescription medicines and consumer healthcare products to assist with weight management, pain management, dermatology, cardiology, respiratory health and allergy care. The company's brands include: Airomir Aldara Alu-Tab Aquae Aquatabs Cepacol Cepacaine ClindaTech Demazin Dermadrate Dermatix DermaVeen Difflam Difflam Gel Diswart Duro-Tuss Duromine EDP Efudix Glucodin Hiprex Invisible Zinc Kynd Lice Breaker Comb Lomotil Medic Room Spray Metsal Minitran Narium Norflex Norgesic Nuelin Nyal Pedoz Pevaryl Reef Retrieve Rikodeine Salvital Stop Itch Plus Tambocor Toppin Ichthammol Ungvita Vermox Virasolve Zidoval
Access this data your way
The Coronis Health Mezzco Pty Ltd Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Coronis Health Mezzco Pty Ltd includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
Coronis Health Mezzco Pty Ltd, trading as iNova Pharmaceuticals, operates under the ABN 43 617 870 416 and was incorporated on 09 March 2017. Coronis Health Mezzco Pty Ltd primarily operates in the Pharmaceuticals Wholesaling industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within Coronis Health Mezzco Pty Ltd, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents Coronis Health Mezzco Pty Ltd’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Coronis Health Mezzco Pty Ltd operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of Coronis Health Mezzco Pty Ltd’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of Coronis Health Mezzco Pty Ltd, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Coronis Health Mezzco Pty Ltd. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of Coronis Health Mezzco Pty Ltd’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is Coronis Health Mezzco Pty Ltd?
Coronis Health Mezzco Pty Ltd, trading as iNova Pharmaceuticals, markets and distributes prescription medicines and consumer healthcare products to assist with weight management, pain management, dermatology, cardiology, respiratory health and allergy care. The company's brands include: Airomir Aldara Alu-Tab Aquae Aquatabs Cepacol Cepacaine ClindaTech Demazin Dermadrate Dermatix DermaVeen Difflam Difflam Gel Diswart Duro-Tuss Duromine EDP Efudix Glucodin Hiprex Invisible Zinc Kynd Lice Breaker Comb Lomotil Medic Room Spray Metsal Minitran Narium Norflex Norgesic Nuelin Nyal Pedoz Pevaryl Reef Retrieve Rikodeine Salvital Stop Itch Plus Tambocor Toppin Ichthammol Ungvita Vermox Virasolve Zidoval
What industry does Coronis Health Mezzco Pty Ltd operate in?
Coronis Health Mezzco Pty Ltd, trading as iNova Pharmaceuticals, is a Private Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry in Australia.
Where is Coronis Health Mezzco Pty Ltd located?
Murray Cod Australia Limited company is based at 12 Help Street, Chatswood, New South Wales, Australia.
Who is the CEO of Coronis Health Mezzco Pty Ltd?
The Managing Director - iNova Group ANZ of Coronis Health Mezzco Pty Ltd is Not Available and the Managing Director - iNova Group ANZ is Andrew Jenkin.
What was Coronis Health Mezzco Pty Ltd’s revenue in 2025?
In 2025, Coronis Health Mezzco Pty Ltd generated total revenue of approximately $193.0 million.
Cut through the noise with intelligence you can trust
